Canadian Oncology Today

Articles

• 

  The Role of ctDNA in Breast Cancer: Prognosis and Clinical Utility

  Mairi Lucas, MD, Stephen K. L. Chia, MD, FRCPC

  6–12

  • PDF (en)
  • PDF (fr)
• 

  Clinical Considerations for the Management of Advanced PD-L1 ≥50% Non-small Cell Lung Cancer In 2025: Should All Patients Be Treated the Same?

  Lorena A. Mija, Arielle Elkrief, MD, FRCPC

  13–17

  • PDF (en)
  • PDF (fr)
• 

  Current Approaches and Future Directions for the Treatment of Solid Tumour Brain Metastases

  Jie Wei Zhu, MD, Ines B. Menjak, MD, Arjun Sahgal, BSc, MD, FRCPC, Katarzyna J. Jerzak, MD, MSc, FRCPC

  18–26

  • PDF (en)
  • PDF (fr)
• 

  The Role of Biomarkers in Upper Gastrointestinal Cancers

  Nathalie Baudoux, MD, Francine Aubin, MD, FRCPC

  27–36

  • PDF (en)
  • PDF (fr)
• 

  Advances in Adjuvant Therapy for High-Risk Breast Cancer: A Canadian Clinical Approach

  Samitha Andrahennadi, MD, Mita Manna, MD, FRCPC

  37–43

  • PDF (en)
  • PDF (fr)